David A. Burns
Directeur Général chez Cellectricon AB
Profil
David A.
Burns currently works at Cellectricon AB, as Chief Executive Officer & Director from 2011.
Mr. Burns also formerly worked at Hammersmith Imanet Ltd., as Chief Executive Officer, GE Healthcare Niagara, Inc., as Chief Executive Officer, Renishaw Diagnostics Ltd., as Chief Executive Officer, Isogenica Ltd., as Non-executive Director, Packard BioScience Co., as Principal, Cyntellect, Inc., as Chief Operating Officer & VP-Sales & Marketing from 2008 to 2010, Pharmacia LKB Biotechnology, Inc., as Principal, PerkinElmer BioSignal, Inc., as Vice President-Business Development & Marketing, and GE UK Group, as Head-Strategic Growth & VP-Commercial Alliances.
Mr. Burns received his undergraduate degree from Napier University.
Postes actifs de David A. Burns
| Sociétés | Poste | Début |
|---|---|---|
Cellectricon AB
 Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Directeur Général | 21/09/2011 |
Anciens postes connus de David A. Burns
| Sociétés | Poste | Fin |
|---|---|---|
Packard BioScience Co.
 Packard BioScience Co. Medical SpecialtiesHealth Technology On July 13, 2001, the company entered into a merger agreement with PerkinElmer, Inc. Pursuant to the merger agreement, the company will become a subsidiary of PerkinElmer and each outstanding share of the company's common stock will be converted into 0.311 of a share of PerkinElmer common stock | Corporate Officer/Principal | - |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Directeur/Membre du Conseil | - |
PerkinElmer BioSignal, Inc.
 PerkinElmer BioSignal, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., PerkinElmer BioSignal, Inc. develops and markets cloned drug targets as drug screening reagents. The company is based in Montréal, Canada. | Sales & Marketing | - |
| GE Healthcare Niagara, Inc. | Directeur Général | - |
Renishaw Diagnostics Ltd.
 Renishaw Diagnostics Ltd. Medical SpecialtiesHealth Technology Renishaw Diagnostics Ltd. provides diagnostic services to detect infectious diseases. The company is headquartered in Edinburgh, the United Kingdom. | Directeur Général | - |
Formation de David A. Burns
| Napier University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Cyntellect, Inc.
 Cyntellect, Inc. Miscellaneous Commercial ServicesCommercial Services Cyntellect, Inc. develops life science technologies. Its products supported key applications to advance life science research, biopharmaceutical production, and stem cell research and drug discovery. The company was founded by Paul R. Billings, Manfred R. Koller and Bernhard O. Palsson in 1997 and was headquartered in San Diego, CA. | Commercial Services |
GE UK Group
 GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Miscellaneous |
| Hammersmith Imanet Ltd. | |
| Pharmacia LKB Biotechnology, Inc. | |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Commercial Services |
Renishaw Diagnostics Ltd.
Renishaw Diagnostics Ltd. Medical SpecialtiesHealth Technology Renishaw Diagnostics Ltd. provides diagnostic services to detect infectious diseases. The company is headquartered in Edinburgh, the United Kingdom. | Health Technology |
PerkinElmer BioSignal, Inc.
PerkinElmer BioSignal, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., PerkinElmer BioSignal, Inc. develops and markets cloned drug targets as drug screening reagents. The company is based in Montréal, Canada. | Commercial Services |
| GE Healthcare Niagara, Inc. | |
Packard BioScience Co.
Packard BioScience Co. Medical SpecialtiesHealth Technology On July 13, 2001, the company entered into a merger agreement with PerkinElmer, Inc. Pursuant to the merger agreement, the company will become a subsidiary of PerkinElmer and each outstanding share of the company's common stock will be converted into 0.311 of a share of PerkinElmer common stock | Health Technology |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Commercial Services |
